Chen Bihua — SEC Form 4 filings
SEC reporting owner CIK 1599214. 30 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2024-01-11 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 56 legs across 14 filings — 8,976,319 shares, $146,649,898 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 23 legs across 8 filings — 9,846,168 shares, $65,260,003 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 3,390,943 shares @ $7.58 ($25,703,348) in MoonLake Immunotherapeutics, filed 2025-10-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 10% owner | 5 | 31 legs · 1,932,632 sh · $53,693,261 | 1 leg · 30,029 sh · $344,012 | — |
| MoonLake Immunotherapeutics (MLTX) | — | 1 | — | 5 legs · 6,499,978 sh · $46,868,184 | — |
| EyePoint, Inc. (EYPT) | — | 4 | 6 legs · 2,286,765 sh · $37,622,267 | 1 leg · 60,000 sh · $942,240 | — |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | Director, 10% owner | 5 | 3 legs · 2,400,000 sh · $24,000,000 | — | 17 |
| BRIGHT MINDS BIOSCIENCES INC. (DRUG) | — | 3 | 12 legs · 606,922 sh · $7,234,370 | 1 leg · 109,331 sh · $9,785,124 | — |
| BioAge Labs, Inc. (BIOA) | — | 1 | 1 leg · 450,000 sh · $8,100,000 | — | 2 |
| Helix Acquisition Corp. III (HLXC) | Chairperson and CEO, Director, 10% owner | 2 | 1 leg · 800,000 sh · $8,000,000 | — | 4 |
| BlossomHill Therapeutics, Inc. (BLSM) | Director, 10% owner | 1 | 1 leg · 312,500 sh · $5,000,000 | — | 5 |
| Immuneering Corp (IMRX) | 10% owner | 2 | — | 13 legs · 1,309,091 sh · $3,909,184 | — |
| OnKure Therapeutics, Inc. (OKUR) | — | 2 | — | 2 legs · 1,837,739 sh · $3,411,258 | — |
+2 more issuers among the filings shown — every filing appears in the table below.
Form 4 filings — Chen Bihua
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | BlossomHill Therapeutics, Inc. (BLSM) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund VI, LP | Conversion (C): 1,599,993 · Conversion (C): 1,701,541 · Purchase (P): 312,500 @ $16 · Grant/award (A): 23,904 (derivative) @ $0 · Conversion (C): 1,599,993 (derivative) · Conversion (C): 1,701,541 (derivative) | EDGAR |
| 2026-07-06 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Other (J): 4,528,186 @ $0 · Other (J): 2,692,459 @ $0 · Other (J): 1,704,862 @ $0 · Other (J): 130,865 @ $0 | EDGAR |
| 2026-06-18 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/award (A): 31,675 (derivative) @ $0 | EDGAR |
| 2026-04-30 | 4 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Sale (S): 109,331 @ $89.50 | EDGAR |
| 2026-01-28 | 4/A | Helix Acquisition Corp. III (HLXC) jointly with Helix Holdings III LLC | Grant/award (A): 497,500 @ $10 · Purchase (P): 800,000 @ $10 · Other (J): 718,750 (derivative) | EDGAR |
| 2026-01-26 | 4 | Helix Acquisition Corp. III (HLXC) jointly with Helix Holdings III LLC | Grant/award (A): 497,500 @ $10 · Other (J): 718,750 (derivative) | EDGAR |
| 2025-12-15 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Sale (S): 30,029 @ $11.46 | EDGAR |
| 2025-12-08 | 4 | EyePoint, Inc. (EYPT) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Sale (S): 60,000 @ $15.70 | EDGAR |
| 2025-10-01 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP | Sale (S): 70,748 @ $9.38 · Sale (S): 232,460 @ $8.40 · Sale (S): 3,390,943 @ $7.58 · Sale (S): 2,800,000 @ $6.61 · Sale (S): 5,827 @ $6.96 | EDGAR |
| 2025-08-13 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Option exercise (M): 4,172,126 · Disposition to issuer (D): 152,940 @ $0 · Grant/award (A): 760,496 @ $10.72 · Grant/award (A): 639,110 @ $10.72 · Grant/award (A): 5,598,425 @ $10.72 · Grant/award (A): 1,905,046 · +4 more | EDGAR |
| 2025-08-01 | 4 | Biomea Fusion, Inc. (BMEA) jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP | Holdings only — no transactions reported | EDGAR |
| 2025-06-13 | 4 | Biomea Fusion, Inc. (BMEA) jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP | Sale (S): 1,813,439 @ $1.85 | EDGAR |
| 2025-05-14 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP | Sale (S): 24,300 @ $1.99 | EDGAR |
| 2025-02-19 | 4 | Aardvark Therapeutics, Inc. (AARD) jointly with Cormorant Asset Management, LP | Conversion (C): 800,189 · Purchase (P): 187,500 @ $16 · Conversion (C): 6,780,810 (derivative) | EDGAR |
| 2025-02-10 | 4 | Helix Acquisition Corp. II (HLXB) | Other (J): 30,000 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) jointly with Cormorant Asset Management, LP | Purchase (P): 184,331 @ $21.70 | EDGAR |
| 2024-10-17 | 4 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 238,097 @ $4.53 · Purchase (P): 63,173 @ $5.92 · Purchase (P): 33,343 @ $6.42 · Purchase (P): 8,900 @ $7.31 · Purchase (P): 2,600 @ $8.80 · Purchase (P): 2,700 @ $9.26 · +5 more | EDGAR |
| 2024-10-01 | 4 | BioAge Labs, Inc. (BIOA) jointly with Cormorant Asset Management, LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund IV LP | Conversion (C): 1,179,529 · Purchase (P): 450,000 @ $18 · Conversion (C): 5,263,772 (derivative) | EDGAR |
| 2024-09-24 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 45,085 @ $17.48 · Purchase (P): 25,943 @ $18.36 · Purchase (P): 66,088 @ $19.61 · Purchase (P): 139,551 @ $20.42 · Purchase (P): 47,564 @ $21.47 · Purchase (P): 25,769 @ $22.23 | EDGAR |
| 2024-06-13 | 4 | Biomea Fusion, Inc. (BMEA) jointly with Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 642,847 @ $11.70 · Purchase (P): 207,153 @ $12.36 | EDGAR |
| 2024-04-22 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 395,244 @ $17.62 · Purchase (P): 186,521 @ $18.90 | EDGAR |
| 2024-04-03 | 4 | Immuneering Corp (IMRX) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Sale (S): 100 @ $3.07 · Sale (S): 300 @ $3.06 · Sale (S): 100 @ $3.05 · Sale (S): 600 @ $3.03 · Sale (S): 10 @ $3.01 · Sale (S): 10 @ $2.98 · +2 more | EDGAR |
| 2024-03-18 | 4 | Immuneering Corp (IMRX) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP | Sale (S): 345,266 @ $3.23 · Sale (S): 98,570 @ $4.25 · Sale (S): 54,215 @ $5.37 · Sale (S): 11,040 @ $5.97 · Sale (S): 400,000 @ $2.14 | EDGAR |
| 2024-03-11 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 46,799 @ $37.82 · Purchase (P): 10,736 @ $39.13 · Purchase (P): 90,325 @ $39.99 · Purchase (P): 102,140 @ $41.23 · Purchase (P): 29,342 @ $41.23 · Purchase (P): 24,983 @ $42.25 · +4 more | EDGAR |
| 2024-02-13 | 4 | Helix Acquisition Corp. II (HLXB) | Grant/award (A): 509,000 @ $10 · Purchase (P): 69,360 @ $10 · Purchase (P): 1,427,040 @ $10 · Purchase (P): 903,600 @ $10 | EDGAR |
| 2024-02-06 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 750,000 @ $19 | EDGAR |
| 2024-01-30 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 14,388 @ $25.73 · Purchase (P): 15,243 @ $26.66 · Purchase (P): 36,747 @ $27.70 · Purchase (P): 31,028 @ $28.82 · Purchase (P): 29,244 @ $29.42 · Purchase (P): 2,654 @ $31 · +8 more | EDGAR |
| 2024-01-11 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP | Purchase (P): 105,000 @ $21.32 · Purchase (P): 750,000 @ $19.75 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1599214 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →